Pharmacological and transcriptomic characterization of the nitric oxide pathway in aortic rings isolated from the tortoise Chelonoidis carbonaria

Comp Biochem Physiol C Toxicol Pharmacol. 2019 Aug:222:82-89. doi: 10.1016/j.cbpc.2019.04.015. Epub 2019 Apr 24.

Abstract

In this study the nitric oxide (NO)-soluble guanylate cyclase (sGC) and phosphodiesterase-5 (PDE-5) pathway was characterized in tortoise Chelonoidis carbonaria aorta. Concentration response curves (CCR) to ATP, ADP, AMP, adenosine and histamine were performed in the presence and absence of L-NAME in aorta pre-contracted with ACh (3 μM). CCR to SNP, BAY 41-2272 (sGC stimulator), BAY 60-2770 (sGC activator) and tadalafil (PDE-5 inhibitor) were constructed in the presence and absence of ODQ (10 μM). ATP (pEC50 6.1 ± 0.1), ADP (pEC50 6.0 ± 0.2), AMP (pEC50 6.8 ± 0.1) and histamine (pEC50 6.8 ± 0.12) relaxed Chelonoidis aorta and the addition of L-NAME reduced their efficacy (p < .05). Adenosine effects (pEC50 6.6 ± 0.1) were not changed in the presence of L-NAME. SNP (pEC50 7.5 ± 0.7; Emax 102.2 ± 2.5%), BAY 41-2272 (pEC50 7.3 ± 0.2; Emax 130.3 ± 10.2%), BAY 60-2770 (pEC50 11.4 ± 0.1; Emax 130.3 ± 6.5%) and tadalafil (pEC50 6.7 ± 0.3; Emax 121.3 ± 15.3%) relaxed Chelonoidis aorta. The addition of ODQ reduced the SNP and tadalafil maximum response (p < .05) and promoted 63 fold right shift on BAY 41-2272 curve. In contrast, no alteration was observed on BAY 60-2770 response. Transcriptomic analysis for eNOS and sGC were found in aorta and brain libraries with high homology when compared with human transcripts. The NO-sGC-PDE-5 is functionally present in Chelonoidis aorta with a functional and genomic similarity to mammalian vessels. Unlike most of mammalian vessels, ACh did not cause endothelium-dependent relaxation in Chelonoidis carbonaria aortic rings.

Keywords: Aorta; Nitric oxide; Reptiles.

MeSH terms

  • Animals
  • Aorta / drug effects*
  • Aorta / metabolism*
  • Brain / drug effects
  • Brain / metabolism
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / genetics
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism
  • Female
  • Gene Expression Regulation / drug effects
  • Histamine / pharmacology
  • Male
  • Nitric Oxide / metabolism*
  • Purinergic Agonists / pharmacology
  • Soluble Guanylyl Cyclase / genetics
  • Soluble Guanylyl Cyclase / metabolism
  • Transcriptome / drug effects*
  • Turtles*
  • Vasoconstriction / drug effects

Substances

  • Purinergic Agonists
  • Nitric Oxide
  • Histamine
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Soluble Guanylyl Cyclase